| |
| Magyar Tüdőgyógyász Társaság |
|
| A DOHÁNYZÁS LESZOKTATÁS ELMÉLETE ÉS MÓDSZERTANA |
 Rendezvény kezdete: 2003.09.26. | Rendezvény vége: 2003.09.26. |
| Tel: 96/ 338 155, 20/9276 925 |
| E-mail: gyenes.monika@enternet.hu |
| Helyszín: Budapest, Szentkirályi u. 14., Pécsi Tudományegyetem, Mosonmagyaróvár, Karolina Kórház |
Előadók:
Prof.Dr. Simon Tamás,
Dr. Balázs Péter,
Prof. Dr. Kopp Mária,
Dr. Horváth Éva,
Dr. Kovács Éva,
Dr. Gyenes Monika
Program, egyéb információ:
A dohányzás epidemiológiája, a leszoktatás pharmakológiája, a dohányzó ember pszichés háttere, a dohányzás leszoktatás lépései
További előadások:
2003. 10.10-én Pécsi Tudományegyetem
2003. 10. 28-án Mosonmagyaróvár, Karolina Kórház tanterme
|
|
|
 |
| |
| Magyar Pszichiátriai Társaság |
|
| International Congress of the World Federation for Mental Health |
| Rendezvény kezdete: 2013.03.06. | Rendezvény vége: 2013.03.09. |
| Szakterület(ek): Pszichiátria, mentálhigiéné |
| Helyszín: Greece, Athens, 28-34 Ath. Diakou Str., 117 43, ROYAL OLYMPIC HOTEL |
| A rendezvény Web oldala: http://psychcongress2013.gr/ |
The main topic of the congress is “Crises and Disasters: Psychosocial consequences”. The WPA sections can play a crucial role in this congress. There is no section that is not directly or indirectly linked with the main topic of the congress. Besides, as you will see in the First Announcement any other topic within the area of mental health would be most welcome.
For more information please visit the web-site of the congress. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
